Cognitive Behavioural Therapy for Acute Insomnia Disorder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of Analytic-Integrative Cognitive Behavioural Therapy (CBT) in treating acute insomnia disorder caused by stress. It focuses on patients who experience difficulties with sleep onset and maintenance due to stressful life events. The approach aims to correct negative sleep cognition and habits while improving overall mental health without the adverse effects associated with medications. Participants will receive individualized treatment plans based on their specific situations to enhance therapeutic outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. meeting the DSM-5 diagnostic criteria for insomnia disorder;
2. a total score of \>5 on the Pittsburgh Sleep Quality Index (PSQI);
3. age ≥18 years old, with junior high school education or above;
4. voluntarily participating in this study and signing an informed consent form;
5. the diagnostic criteria for acute insomnia disorder (duration of the disease less than 3 months).

Exclusion Criteria:

1. people with comorbid serious physical or severe mental illnesses, suicide risk;
2. clinically diagnosed or suspected sleep breathing disorder, restless legs syndrome and sleep-wake rhythm disorder, shift workers;
3. pregnant and breastfeeding women;
4. people who are currently undergoing any psychological treatment.

Where it's running

• Xuanwu Hospital, Capital Medical University
  Beijing, China Recruiting

Study contacts

• Study coordinator: Hongxing Wang, MD & PhD
• Email: wanghongxing@xwh.ccmu.edu.cn
• Phone: +86 13911127385

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acoustic Stimulation During Sleep for Alzheimer’s Disease

  Researchers test whether playing gentle sounds during sleep can help people with Alzheimer’s disease see if their thinking improves compared with a sham sound.

  Recruiting Xuanwu Hospital, Beijing · Beijing · NCT07924657

• See if multimodal biomarkers can map changes from mild cognitive impairment to dementia

  This observational study tests whether clinical, blood, and brain-imaging markers can tell apart stages of cognitive decline and predict progression from mild cognitive impairment to dementia in about 600 people.

  Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT07876570

• Satralizumab in the early treatment of NMOSD attacks: a multicenter real-world study

  This study tests whether starting Satralizumab during an NMOSD attack is safe and helpful for adults with AQP4-IgG–positive NMOSD.

  Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT07762872

• Real-World Experience With the WEB Device for Intracranial Aneurysms

  This study tests how well the Woven EndoBridge device works in routine treatment of intracranial aneurysms in China across multiple centers.

  Recruiting Xuanwu Hospital, Beijing · Beijing · NCT07620626

• Multicenter Registry of Intracranial Dural Arteriovenous Fistulas in China

  This study will collect and analyze data from many hospitals in China to see how common intracranial dural AV fistulas are, how they’re treated, and what outcomes look like for patients.

  Recruiting Xuanwu Hospital, Beijing · Beijing · NCT07604688

• Preventive Analgesia With Anrikefon in Laparoscopic Gallbladder Surgery

  This study tests whether giving Anrikefon before or during laparoscopic cholecystectomy can reduce early postoperative pain.

  Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT07566663

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.